Cardiovascular disease has a multifactorial aetiology, as is illustrat
ed by the existence of numerous risk indicators, many of which can be
influenced by dietary means. It should be recalled, however, that only
after a cause-and-effect relationship has been established between th
e disease and a given risk indicator (called a risk factor in that cas
e), can modifying this factor be expected to affect disease morbidity
and mortality. In this paper, effects of diet on cardiovascular risk a
re reviewed, with special emphasis on modification of the plasma Lipop
rotein profile and of hypertension. In addition, dietary influences on
arterial thrombotic processes, immunological interactions, insulin re
sistance and hyperhomocysteinaemia are discussed. Dietary Lipids are a
ble to affect lipoprotein metabolism in a significant way, thereby mod
ifying the. risk of cardiovascular disease. However, more research is
required concerning the possible interactions between the:various diet
ary fatty acids, and between fatty acids and dietary cholesterol. In a
ddition, more studies are needed with respect to the possible importan
ce of the postprandial state. Although in the aetiology df hypertensio
n the genetic component is definitely stronger than environmental fact
ors, some benefit in terms of the development and coronary complicatio
ns of atherosclerosis in hypertensive patients can be expected from fa
tty acids such as ol-linolenic acid, eicosapentaenoic acid and docosah
exaenoic acid. This particularly holds for those subjects where the hy
pertensive mechanism involves the formation of thromboxane Az and/or a
lpha 1-adrenergic activities. However, large-scale trials are required
to test this contention. Certain aspects of blood platelet function,
blood coagulability,:and fibrinolytic activity are associated with car
diovascular risk, but causality has been insufficiently proven. Noneth
eless, well-designed intervention studies should be initiated to furth
er evaluate such promising dietary components as the various n-3 and n
-6 fatty acids and their combination, antioxidants, fibre, etc. for th
eir effect on processes participating in arterial thrombus formation.
Long-chain polyenes of the n-3 family and antioxidants can modify the-
activity of immunocompetent cells, but we are at an early stage of exa
mining the role pf immune function on the development of atherosclerot
ic plaques. Actually, there is little, if any, evidence that dietary m
odulation of immune system responses of cells participating in atherog
enesis exerts beneficial effects. Although it seems feasible to modula
te insulin sensitivity and subsequent cardiovascular risk factors by d
ecreasing the total amount of dietary fat and increasing the proportio
n of polyunsaturated fatty acids, additional studies on the efficacy o
f specific fatty acids, dietary fibre, and low-energy diets, as well a
s on the mechanisms involved are required to understand the real funct
ion of these dietary components. Finally, dietary supplements containi
ng folate and vitamins B-6 and/or B-12 should bd tested for their pote
ntial to reduce cardiovascular risk by lowering the plasma level of ho
mocysteine.